ECVT:NYSEEcovyst Inc. Analysis
Data as of 2026-03-30 - not real-time
$13.21
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ecovyst Inc. is trading in a bullish technical environment, with the 20‑day SMA comfortably above the 50‑day SMA and a bullish MACD crossover reinforcing upward momentum. RSI is well above the 70 threshold, signaling that the stock is technically overbought, while volume is on an increasing trend, supporting the price advance. The price sits just above the ten‑dollar support level and is approaching the thirteen‑dollar resistance zone, suggesting limited upside in the immediate term.
Fundamentally, the company reports rapid revenue growth of over 30% year‑over‑year and a forward P/E near the mid‑teens, contrasting sharply with a trailing P/E that is extraordinarily high. The DCF analysis points to a fair value substantially above the current market price, implying a modest upside potential. However, profitability remains a concern, with a negative profit margin and modest return on equity, while the balance sheet shows a debt‑to‑equity ratio above 70%, indicating leverage risk.
Fundamentally, the company reports rapid revenue growth of over 30% year‑over‑year and a forward P/E near the mid‑teens, contrasting sharply with a trailing P/E that is extraordinarily high. The DCF analysis points to a fair value substantially above the current market price, implying a modest upside potential. However, profitability remains a concern, with a negative profit margin and modest return on equity, while the balance sheet shows a debt‑to‑equity ratio above 70%, indicating leverage risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in overbought territory
- Proximity to resistance near $13
- Strong bullish MACD signal
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value indicating upside
- Forward earnings growth and modest forward P/E
- Robust revenue growth trajectory
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained top‑line growth in specialty chemicals
- Strategic portfolio moves enhancing market position
- Long‑term demand drivers for sulfuric acid and related products
Key Metrics & Analysis
Financial Health
Revenue Growth34.00%
Profit Margin-9.83%
P/E Ratio264.2
ROE0.96%
ROA3.06%
Debt/Equity71.59
P/B Ratio2.4
Op. Cash Flow$140.3M
Free Cash Flow$102.9M
Technical Analysis
TrendBullish
RSI72.2
Support$10.78
Resistance$13.27
MA 20$11.87
MA 50$11.45
MA 200$9.48
MACDBullish
VolumeIncreasing
Fear & Greed Index67.95
Valuation
Fair Value$30.82
Target Price$14.20
Upside/Downside7.49%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta1.13
Volatility31.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.